Urology News Feeds
Patient-reported outcomes in penile cancer patients: Quality of life, sexual and urinary function. What do we know?
Penile cancer is a rare genitourinary malignancy disease responsible for less than 1% of diagnosed cancers in men in the USA, with mortality reported to 300 deaths for a year1. However, its incidence varies according to the population studied, with multiple risk factors described and usually diagnosed in men over 50 years. Historically, surgery has been the cornerstone of the treatment of the disease, achieving satisfactory oncological outcomes but with a high cost at generating a disastrous impact on the quality of life and the male mind for the post-treatment sequels2.
Ileal Conduit versus Continent Urinary Diversion in Radical Cystectomy: A Retrospective Cohort Study of 30-day Complications, Readmissions, and Mortality
To quantify the short-term burden associated with continent diversion relative to ileal conduit creation.
Safety and efficacy of Phenylephrine administration for the treatment of ischemic priapism: An opportunity for quality improvement in periprocedural safety assessment
To determine the safety and efficacy of hourly, high dose phenylephrine (>1000 μg) for acute ischemic priapism (AIP) through monitoring adverse hemodynamic events amongst risk profiles.
To develop a novel “bootcamp” simulation-based curriculum to introduce common urologic procedures and to improve readiness for performing them at bedside.
Recurrent UPJ obstruction following paediatric pyeloplasty is associated with an initial <2.5cm incision open surgical approach
To determine the risk factors that affect surgical outcomes for pediatric pyeloplasty, and whether this may be related to the choice of operative approach.
Robot-assisted Laparoscopic Bilateral Ileal Ureter in Duplex Ureter with Strictures after Treatment Failure of Allium Stents
Ureteral injury and vaginal fistula are common complications after surgical treatment and radiotherapy of gynecological tumor1,2. Ureteral injury in duplex system is more challenging and rarely reported3.
To report our experience and outcomes in minimally invasive management of rectourethral fistula (RUF).
To present a case series of three post-pubertal adolescent males with Chlamydia trachomatis presenting as scrotal masses. Scrotal masses are worrisome for malignancy, especially when imaging confirms intratesticular lesions. However, there are benign conditions which may mimic testicular cancer. Some of these conditions may not be readily considered in the pediatric population. This phenomenon is rare in the pediatric population, and this represents only the second report in the literature of this finding.
A 46-year-old man with sickle cell anemia was taken to the operating room for resection of a 19cm right-sided retroperitoneal mass identified on CT performed for flank pain (Figure 1A). The mass was removed en bloc with the adrenal and kidney (Figure 1B). Hepatic mobilization with ligation of the venous branches draining the caudate lobe and the right hepatic artery was performed along with a small, non-anatomical partial hepatectomy at a location where the mass was densely adherent to the liver.
Letter to the editor- Expectant Management of Blunt Grade III Renal Injuries: Early Discharge Outcomes from a Level 1 Trauma Center
We read the recent article by George et al published in Urology with great interest1. In their retrospective comparing early vs late discharge in patients with grade 3 renal trauma, they concluded that patients with blunt renal injuries are not at increased risk for early renal-related complications, if discharged within 48 hours of admission. They stated that these patients, be categorized as ‘low-grade” renal trauma, since they observed a very low rate of renal-related complications in them. The authors further stated that no patient required readmission for kidney related complications.
Eponyms are a long-standing tradition in the medical field, usually to honor a prominent physician or scientist that has played a significant role in the identification of anatomy or pathology. Various eponyms occur in urology from Fournier to Foley, honoring physicians that have helped progress the field of urology. While eponyms are meant as a tribute to those that have made tremendous advancements in medicine; recent investigation into the origin of eponyms spanning various specialties has revealed those honored may not represent individuals worthy of recognition.
Response to Letter to the Editor Re: Expectant Management of Blunt Grade III Renal Injuries: Early Discharge Outcomes from a Level 1 Trauma Center
Thank you for your interest in our manuscript and the opportunity to further discuss our work. While ICD codes were used initially to identify patients from our institutional trauma registry, each patient's imaging was individually reviewed and re-graded by independent radiologists strictly for the purposes of this study. The ability to have these gradings verified allowed us the opportunity to be confident in our conclusions and not base them on administrative coding alone.
Testosterone therapy (TT) is an effective treatment for hypogonadal symptoms in men with testosterone deficiency. However, TT may also be associated with potential side effects, such as polycythemia and abnormal liver function, both of which are considered dose-dependent with higher risk associated with higher levels of serum testosterone (T).1,2 Despite prior studies indicating an association between TT and these adverse effects, the precise T levels and thresholds above which there is increased morbidity are not known.
To better understand renal nutcracker syndrome (NCS) from a patients’ perspective starting at presentation and followed through to diagnosis and management
Prospective cross-sectional evaluation of penile helicine circulation by power doppler during dynamic ultrasound in veno-occlusive erectile dysfunction
To evaluate the usefulness of Power Doppler to improve the diagnostic work up of veno-occlusive erectile dysfunction patients.
To report perioperative and postoperative outcomes in men who undergo salvage RASP (sRASP) following some other endoscopic outlet procedure for benign prostate enlargement (BPE) compared to those undergoing RASP for primary treatment (pRASP).
On May 30th of this year all of us lost one of our brightest lights and exemplary individuals. As a family man, caregiver, surgeon, educator, advisor and counselor, administrator, colleague and friend, Douglas (Doug) Canning was an example of what could be termed “a man without a vice”. As we at Penn sat around a table later that week at a meeting called to talk about our emotions and thoughts regarding this tragedy, numerous anecdotes were recounted which remind us of the positive influences he had on each of us in so many areas of life and practice.
We are very pleased that the authors of this letter carefully reviewed our study published a decade and half ago and pointed out the discrepancy that the values reported for the control group do not lie in the range expected. After this prolonged time, authors have retired (or cannot be found), the technician who collected the specimens has died, the labs have closed, and the original hard data cannot be found. It seems we likely reported the reference range in ng/dL and the test results for testosterone and progesterone in ng/ml.
Letter to the editor regarding the article "Adrenocortical hormone abnormalities in men with chronic prostatitis/chronic pelvic pain syndrome"
We read with interest the article "Adrenocortical hormone abnormalities in men with chronic prostatitis/chronic pelvic pain syndrome"1 published in February 2008 in the Urology journal, volume 71, issue 2. The article describes a study of men with chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS). The authors of the study observed mineralocorticoid steroid abnormalities in CP/CPPS patients, suggesting 21-hydroxylase deficiency (21OHD) associated with non-classic congenital adrenal hyperplasia, a condition generally thought to be asymptomatic in men.
To evaluate how blood levels of prostate-specific antigen (PSA) relate to prostate volume of benign tissue, Gleason pattern 3 (GP3) and Gleason pattern 4 (GP4) cancer.